The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT
• AZD7325 is an orally administered, potent, selective gamma‐amino‐butyric acid (GABAA) α2,3 receptor modulator intended for the treatment of anxiety.
• The induction effects of AZD7325 on CYP1A2 and CYP3A4 have not been systematically studied.
WHAT THIS STUDY ADDS
• The in vitro studies showed that AZD7325 was a moderate CYP1A2 inducer and potent CYP3A4 inducer...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.